Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action

Regulations by 2FIRSTS.ai
Dec.22.2023
Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action
World Health Organization (WHO) states that there is no evidence that e-cigarettes effectively help smokers quit. Instead, evidence shows negative impacts on public health.

The World Health Organization (WHO) categorically states that there is no evidence to suggest that e-cigarettes can effectively assist community smokers in quitting smoking. On the contrary, there is existing evidence that indicates e-cigarettes have a negative impact on public health.

 

E-cigarettes have been widely available on the market and extensively promoted among young people. Currently, 34 countries have implemented bans on the sales of e-cigarettes, while 88 countries lack any minimum age restrictions for purchasing e-cigarettes. Additionally, 74 countries have no regulations in place regarding these harmful products.

 

World Health Organization Director-General Tedros Adhanom Ghebreyesus emphasized that "children are being lured into smoking and may become addicted to nicotine at a young age. I urge countries to implement strict measures to prevent the use of e-cigarettes in order to protect their citizens, especially children and adolescents.

 

E-cigarettes, which contain highly addictive nicotine, are harmful to health. While we have not yet fully understood their long-term effects on health, it has been established that they produce harmful substances, some of which are considered carcinogens, while others increase the risk of heart and lung diseases. The use of e-cigarettes may also affect brain development, leading to learning and cognitive impairments in young people. Pregnant women exposed to e-cigarettes may have adverse effects on the development of the fetus. The toxic gases in e-cigarettes also pose risks to those around the users.

 

The usage of e-cigarettes among children aged 13-15 is reported in all regions of the World Health Organization. In Canada, the prevalence of e-cigarette use among individuals aged 16-19 has doubled between 2017 and 2022. Similarly, in the UK, the number of teenagers using e-cigarettes has tripled in the past three years.

 

Research consistently indicates that even brief exposure to social media content about e-cigarettes can potentially increase both the willingness to use these products and the positive attitude towards e-cigarettes. Young people who use e-cigarettes are nearly three times more likely to use traditional cigarettes in the future.

 

The World Health Organization (WHO) has called on countries to take urgent measures to prevent the use of e-cigarettes and nicotine addiction, as well as to implement comprehensive tobacco control methods that align with each country's respective circumstances. In countries where the sale of e-cigarettes is prohibited, the WHO urges stronger enforcement of such bans and continuous monitoring to support public health interventions and ensure strict compliance. In countries where the sale of e-cigarettes as consumer products (including sales, imports, distribution, and production) is permitted, the WHO emphasizes the need for strict regulations to reduce their attractiveness and harm to the public. This includes the prohibition of all flavors, limitations on nicotine concentration and content, as well as taxation.

 

The strategy for smoking cessation should be based on the best available evidence and should be accompanied by other tobacco control measures, and it should be monitored and evaluated. According to the current evidence, the government should not allow the sales of e-cigarettes as consumer products in order to achieve the goal of smoking cessation.

 

Any government that adopts an e-cigarette smoking cessation strategy must regulate the conditions of product exposure to ensure proper clinical conditions and manage drug products (including requiring them to be distributed as pharmaceuticals). Even in such strict forms, the decision to pursue e-cigarettes as a means to achieve smoking cessation goals should only be made after reviewing domestic conditions, as well as examining smoking risks and proven cessation strategies.

 

Due to the growing prevalence of e-cigarette use, which has been found to have harmful effects on the health of children and adolescents, decisive action must be taken to prevent the use of e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026 will bring together international experts to discuss European regulation, tax policy, Track & Trace, market access, retail impacts, consumer behavior and innovation. Sessions will also examine Poland’s tobacco-growing perspective and the growing fragmentation of Europe’s tobacco and nicotine market. Media partner 2FIRSTS will host the second “2FIRSTS Connect at InterTabac” on September 16, focusing on developments in China’s tobacco and nicotine industry.
Aug.06
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31
2Firsts Data | China’s U.S. Vape Exports Have Yet to Regain Previous Growth Momentum in H1 2026, but Hardware Grew 15.2% and 6-Methyl Nicotine-Related Products Rose 234.7%
2Firsts Data | China’s U.S. Vape Exports Have Yet to Regain Previous Growth Momentum in H1 2026, but Hardware Grew 15.2% and 6-Methyl Nicotine-Related Products Rose 234.7%
China’s vape exports to the U.S. reached approximately $1.58 billion in the first half of 2026, remaining broadly stable from a year earlier but still below previous growth momentum. 2Firsts’ analysis of China Customs data shows that the U.S. market has not simply returned to its previous trajectory after the enforcement shock and inventory-driven swings of 2025. Instead, export momentum is shifting across product categories. Vaping devices and atomization hardware increased 15.2% year over year, while 6-methyl nicotine-related and other nicotine substitute products surged 234.7%. Meanwhile, traditional nicotine-containing vaping products continued to face pressure.
Jul.22